Published in Bull Exp Biol Med on November 01, 2001
NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol (2008) 2.13
Neuroprotective strategies involving ROS in Alzheimer disease. Free Radic Biol Med (2010) 1.57
Polycyclic compounds: ideal drug scaffolds for the design of multiple mechanism drugs? Neurotherapeutics (2009) 1.53
Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta (2009) 1.25
Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid-beta levels in vitro and in vivo. Mol Neurodegener (2009) 1.18
Evaluation of Dimebon in cellular model of Huntington's disease. Mol Neurodegener (2008) 1.14
Neuronal calcium signaling, mitochondrial dysfunction, and Alzheimer's disease. J Alzheimers Dis (2010) 1.04
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model. Mol Psychiatry (2012) 0.99
Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease. J Alzheimers Dis (2010) 0.95
Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps. Psychopharmacology (Berl) (2008) 0.92
The rise and fall of Dimebon. Drug News Perspect (2010) 0.92
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease? Mol Neurobiol (2010) 0.92
Current treatment and recent clinical research in Alzheimer's disease. Mt Sinai J Med (2010) 0.92
Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice. Neurotox Res (2011) 0.92
Translatability scoring in drug development: eight case studies. J Transl Med (2012) 0.89
Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurol (2010) 0.89
Preclinical study of dimebon on β-amyloid-mediated neuropathology in Alzheimer's disease. Mol Neurodegener (2011) 0.88
Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast. J Alzheimers Dis (2012) 0.88
Dimebon disappointment. Alzheimers Res Ther (2010) 0.88
Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases. Transl Psychiatry (2013) 0.87
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers. J Med Chem (2013) 0.84
Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea. Curr Opin Investig Drugs (2010) 0.84
Novel therapeutics for Alzheimer's disease: an update. Curr Opin Drug Discov Devel (2010) 0.84
Alzheimer's disease and age-related memory decline (preclinical). Pharmacol Biochem Behav (2011) 0.83
The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. Br J Pharmacol (2011) 0.82
Dimebon inhibits calcium-induced swelling of rat brain mitochondria but does not alter calcium retention or cytochrome C release. Neuromolecular Med (2010) 0.79
Dimebon does not ameliorate pathological changes caused by expression of truncated (1-120) human alpha-synuclein in dopaminergic neurons of transgenic mice. Neurodegener Dis (2011) 0.77
Mitochondrial Drugs for Alzheimer Disease. Pharmaceuticals (Basel) (2009) 0.76
Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately? Open Neurol J (2009) 0.75
Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Neurotherapeutics (2015) 0.75
The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity. J Alzheimers Dis (2016) 0.75
Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull Exp Biol Med (2003) 1.36
Dimebon improves learning in animals with experimental Alzheimer's disease. Bull Exp Biol Med (2000) 1.32
[Proteinopathies--forms of neurodegenerative disorders with protein aggregation-based pathology]. Mol Biol (Mosk) (2012) 0.93
Effect of beta-amyloid peptide fragment 25-35 on nonselective permeability of mitochondria. Bull Exp Biol Med (2001) 0.91
[Modeling of lateral amyotrophic sclerosis: a transgenic method]. Zh Nevrol Psikhiatr Im S S Korsakova (2013) 0.89
FUS gene mutations associated with familiar forms of amyotrophic lateral sclerosis affect cellular localization and aggregation properties of the encoded protein. Dokl Biochem Biophys (2011) 0.84
[Inhibition of enzymatic activity of alpha-thrombin by low molecular weight synthetic inhibitor]. Biokhimiia (1992) 0.83
[New aspects of the pathogenesis of lateral amyotrophic sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.83
Synthesis and antioxidative activity of metalloporphyrins bearing 2,6-di-tert-butylphenol pendants. J Inorg Biochem (2008) 0.82
Interaction of docosahexaenoic acid derivatives with mitochondria. Dokl Biol Sci (2007) 0.81
The effect of dithiocarbamates on neurotoxic action of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) and on mitochondrial respiration chain. Neurotoxicology (1997) 0.81
Impaired spatial and working memory in ageing mice with targeted inactivation of α-synuclein gene. Dokl Biol Sci (2012) 0.81
Inhibition of NADH oxidation by 1-methyl-4-phenylpyridinium analogs as the basis for the prediction of the inhibitory potency of novel compounds. J Biochem Toxicol (1996) 0.80
The influence of heparin and indol on the catalytic properties of alpha- and beta/gamma -thrombins. Thromb Res (1981) 0.80
[Effects of chronic administration of dimebon on behavior and memory of SAMP 10 mice]. Eksp Klin Farmakol (2009) 0.79
[Targeted inactivation of gamma-synuclein gene affects anxiety and exploratory behaviour of mice]. Zh Vyssh Nerv Deiat Im I P Pavlova (2011) 0.78
Dimebon activates autophagosome components in human neuroblastoma SH-SY5Y cells. Dokl Biochem Biophys (2012) 0.77
Autoantibodies to beta-amyloid and neurotransmitters in patients with Alzheimer's disease and senile dementia of the Alzheimer type. Bull Exp Biol Med (2001) 0.77
Disturbed assembly of human cerebral microtubules in Alzheimer's disease. Bull Exp Biol Med (2006) 0.76
Effect of tacrine, amiridine, akatinol memantine, and triazolam on phosphorylation, structure, and assembly of microtubules from brain microtubular proteins in Alzheimer diseases. Bull Exp Biol Med (2008) 0.76
Mechanisms of antioxidant effect of natural sesquiterpene lactone and alkaloid derivatives. Bull Exp Biol Med (2012) 0.76
Dimebon reduces the levels of aggregated amyloidogenic protein forms in detergent-insoluble fractions in vivo. Bull Exp Biol Med (2012) 0.76
[The influence of some retarding agents NOS of dihydrothiazine-thiazoline rank on postradiational of recovery endogenous CFU-S-8 of mice]. Radiats Biol Radioecol (2007) 0.76
Comparison of the effect of NT-0409 and antidementia drugs on learning and memory in rats with chronic cerebral cholinergic deficiency. Bull Exp Biol Med (2003) 0.75
Antioxidative activity of ferrocenes bearing 2,6-di-tert-butylphenol moieties. Bioinorg Chem Appl (2010) 0.75
Thrombin-mediated events implicated in mast cell activation. Semin Thromb Hemost (1996) 0.75
Effects of anti-Alzheimer drugs on phosphorylation and assembly of microtubules from brain microtubular proteins. Bull Exp Biol Med (2014) 0.75
Content of autoantibodies to bradykinin and beta-amyloid(1-42) as a criterion for biochemical differences between Alzheimer's dementias. Bull Exp Biol Med (2003) 0.75
[Modulation of the platelet aggregation capacity by modified forms of thrombin]. Biokhimiia (1985) 0.75
[Regulation of thrombocyte stimulating and other activities of thrombin by modulators of the recognition site]. Vestn Akad Med Nauk SSSR (1991) 0.75
Gamma-synuclein binds synaptic vesicles but does not interact with SNARE-complex proteins. Dokl Biochem Biophys (2014) 0.75
[Hypotensive effect and anti-monoaminoxidase activity of fluoronitrocarbonic acid hydrazides]. Dokl Akad Nauk SSSR (1989) 0.75
[Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism]. Biull Eksp Biol Med (1989) 0.75
[The immunoregulator alpha-1-thymosin as an inhibitor of alpha thrombin enzymatic activity]. Dokl Akad Nauk SSSR (1989) 0.75
[Immunoenzyme assay for detection of natural antibodies against vasopressin in systemic lupus erythematosus]. Klin Lab Diagn (1999) 0.75
[Clinical and biochemical parameters of parkinsonism induced by 1-methyl-4-phenyl-1,2,2,6-tetrahydropyridine and its methyl-phenyl and methoxy-phenyl derivatives in C57Bl/6 mice]. Biull Eksp Biol Med (1990) 0.75
Gamma-carboline inhibits neurodegenerative processes in a transgenic model of amyotrophic lateral sclerosis. Dokl Biochem Biophys (2015) 0.75
[Effect of nooglutyl on the behavior and memory of SAMP10 mice with genetically determined accelerated aging]. Eksp Klin Farmakol (2007) 0.75
The action of the peptide drug Semax on the currents of AMPA receptors of rat cerebellar Purkinje cells. Dokl Biochem Biophys (2015) 0.75
[Effect of prethrombin I and prostaglandin E2 on thrombin-stimulated aggregation of rat platelets]. Vopr Med Khim (1985) 0.75
Effects of delta sleep-inducing peptide on pre- and postsynaptic glutamate and postsynaptic GABA receptors in neurons of the cortex, hippocampus, and cerebellum in rats. Bull Exp Biol Med (2006) 0.75
Binary mechanism of action of cognition enhancer NT1505 on glutamate receptors. Bull Exp Biol Med (2012) 0.75
[Effect of thrombomodulin on specific thrombin functions: fibrinogen coagulation and thrombocyte aggregation]. Biull Eksp Biol Med (1988) 0.75
[Stationary kinetics of catalysis by the hydrogenase of Thiocapsa roseopersicina]. Mol Biol (Mosk) (1978) 0.75
[Simultaneous AMPA receptor potentiation and NMDA receptor blockade as strategy for creating effective stimulants for cognitive functions]. Eksp Klin Farmakol (2010) 0.75
[2-Amino-2-thiazoline derivatives--a novel chemotype possessing muscarinomimetic effect]. Biomed Khim (2003) 0.75
Modulatory action of kainic acid on glutamate release from rat brain cortical synaptosomes. Ann N Y Acad Sci (1992) 0.75
[A mice model of amyotrophic lateral sclerosis expressing mutant human FUS protein]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.75
Oxidation of tetrahydrostilbazole by monoamine oxidase A demonstrates the effect of alternate pathways in the kinetic mechanism. Biochemistry (1993) 0.75
[Effects of estrogens on learning of rats with chronic brain cholinergic deficit in Morris water maze]. Zh Vyssh Nerv Deiat Im I P Pavlova (2003) 0.75
Effect of somatostatin on presynaptic and postsynaptic glutamate receptors and postsynaptic GABA receptors in the neurons of rat brain. Bull Exp Biol Med (2012) 0.75
N,N-disubstituted 2-aminothiazolines as new inhibitors of serine esterases. Dokl Biochem Biophys (2013) 0.75
[Catalytic biotransformation of physiologically active 1-methyl-4- aryl-1,2,3,6-tetrahydropyridines under the action of monoaminooxidase]. Bioorg Khim (1989) 0.75
[Device for recording the activity of single channels in nerve and muscle cells]. Fiziol Zh SSSR Im I M Sechenova (1985) 0.75
[The structure-activity relationship in the dehydrogenation processes of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) analogs under the action of MAO]. Dokl Akad Nauk SSSR (1991) 0.75
[Modeling of lateral amyotrophic sclerosis: a non-genetic method]. Zh Nevrol Psikhiatr Im S S Korsakova (2013) 0.75
[Hydrolysis of methyl esters of N alpha-arylsulfonyl-arginine and N-arylsulfonyl-valyl-arginine by alpha- and beta/gamma-thrombins]. Biokhimiia (1982) 0.75
[Inhibition of the dopamine reuptake system by analogs of the neurotoxic metabolite MPP (1-methyl-4-phenylpyridine). The structure-activity relationship]. Dokl Akad Nauk (1996) 0.75
Glutamate receptor modulator dimebon stimulates consolidation and reconsolidation of weak memory in chicks. Bull Exp Biol Med (2012) 0.75
[The role of the system of reverse capture of dopamine in the development of experimental Parkinsonism under the effect of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and its pyridine analogs]. Dokl Akad Nauk SSSR (1989) 0.75
Versatile computerized system for tracking and analysis of water maze tests. Behav Res Methods Instrum Comput (2001) 0.75
[Molecular aspects of the pathogenesis and current approaches to pharmacological correction of Alzheimer's disease]. Zh Nevrol Psikhiatr Im S S Korsakova (2015) 0.75
Oxidation products arising from the action of monoamine oxidase B on 1-methyl-4-benzyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem (1994) 0.75
Stylbasole analogues of MPTP as monoamine oxidase (MAO) substrates. J Neural Transm Suppl (1990) 0.75
[Molecular changes in inbred mice with individual vulnerability vs resilience to stress-induced depressive-like state]. Ross Fiziol Zh Im I M Sechenova (2011) 0.75
[Study of the neuroprotective action of hybrid structures based on fullerene C60]. Izv Akad Nauk Ser Biol (2011) 0.75
Interaction of tetrahydrostilbazoles with monoamine oxidase A and B. J Med Chem (1994) 0.75
The effects of estrogens on learning in rats with chronic brain cholinergic deficiency in a Morris water test. Identification of the "passive swimming" component. Neurosci Behav Physiol (2004) 0.75
[Kininogenase activity of alpha and beta/gamma forms of bovine thrombin]. Biokhimiia (1984) 0.75
[Study into molecular targets of a neuroprotective compound dimebon using a transgenic mice line]. Biomed Khim (2014) 0.75
[Membrane potential fixation using an oscillograph]. Fiziol Zh SSSR Im I M Sechenova (1985) 0.75
[Dithiocarbamates amplify the neurotoxic effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its analogs]. Dokl Akad Nauk (1993) 0.75
Effect of corticotropin-like intermediate lobe peptide on presynaptic and postsynaptic glutamate receptors and postsynaptic GABA receptors in rat brain. Bull Exp Biol Med (2009) 0.75
[Regulation of alpha and beta/gamma-thrombin activity by heparin and indole]. Biokhimiia (1980) 0.75
[Mitochondria as the target for neuroprotectors]. Vestn Ross Akad Med Nauk (2005) 0.75
Substrate activation in the thrombin-catalyzed hydrolysis of synthetic esters of arginine. Thromb Res (1978) 0.75
[Autocatalytic enzyme reactions]. Mol Biol (Mosk) (1979) 0.75
[Influence of derivatives of arachidonic and docosohexaenic acids on AMPA receptors in Purkinje neurons and cognitive functions in mice]. Izv Akad Nauk Ser Biol (2010) 0.75
Effects of 17 beta-estradiol and its isomer 17 alpha-estradiol on learning in rats with chronic cholinergic deficiency in the brain. Bull Exp Biol Med (2000) 0.75
[Enzymatic hydrolysis and reversible binding of suberyldicholine by cholinesterases]. Vopr Med Khim (1977) 0.75